ACLX

Arcellx, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Elghandour RamiDirector, Officer: SEE REMARKS
$10M89.9k shares
SellFeb 27, 2026
$113.92
--
Gilson MichelleCHIEF FINANCIAL OFFICER
$1.3M11.2k shares
SellFeb 25, 2026
$113.82
--
Gilson MichelleCHIEF FINANCIAL OFFICER
$371k5.4k shares
SellFeb 19, 2026
$68.57
--
Gilson MichelleCHIEF FINANCIAL OFFICER
$195k2.9k shares
SellFeb 19, 2026
$67.73
--
Gilson MichelleCHIEF FINANCIAL OFFICER
$6.9k100 shares
SellFeb 19, 2026
$69.38
--
Gilson MichelleCHIEF FINANCIAL OFFICER
$494k7.1k shares
SellFeb 17, 2026
$69.21
--

News

businesswire.comGilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-celbusinesswire.comApr 28zacks.comAre Medical Stocks Lagging Arcellx (ACLX) This Year?zacks.comApr 27defenseworld.netArcellx, Inc. (NASDAQ:ACLX) Given Consensus Recommendation of “Hold” by Analystsdefenseworld.netApr 24businesswire.comGilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offerbusinesswire.comApr 17defenseworld.netBanque Pictet & Cie SA Acquires Shares of 5,109 Arcellx, Inc. $ACLXdefenseworld.netApr 4